-
Play video Webinar: Diversity, Equity and Inclusion in Rare Disease Clinical Trials
Webinar: Diversity, Equity and Inclusion in Rare Disease Clinical Trials
1:14:41
-
Play video Webinar: Hot flashes, brain fog and the blues
Webinar: Hot flashes, brain fog and the blues
58:34
-
Play video Patient-centric trial development toolkit - rare diseases
Patient-centric trial development toolkit - rare diseases
57:01
-
Play video Reflections on paediatric assent: Have we outgrown this concept?
Reflections on paediatric assent: Have we outgrown this concept?
In this webinar, medical ethicists will discuss what investigators, ethics committees, IRBs and – ideally – sponsors can do to reverse this trend and create documents which achieve their intended purpose of allowing a child to understand their trial.
1:02:52
-
Play video Rare Disease Registries: Practical Ways to Build Trust with Patient Advocacy Groups
Rare Disease Registries: Practical Ways to Build Trust with Patient Advocacy Groups
With the right planning and understanding, collaboration between drug development companies and patient advocacy groups (PAGs) can be mutually beneficial in a number of key areas.
1:02:03
-
Play video Rare Disease Registries: Practical Ways to Build Trust with Patient Advocacy Groups
Rare Disease Registries: Practical Ways to Build Trust with Patient Advocacy Groups
With the right planning and understanding, collaboration between drug development companies and patient advocacy groups (PAGs) can be mutually beneficial in a number of key areas.
1:02:03
-
Play video Rare Disease Registries: Practical Ways to Build Trust with Patient Advocacy Groups
Rare Disease Registries: Practical Ways to Build Trust with Patient Advocacy Groups
With the right planning and understanding, collaboration between drug development companies and patient advocacy groups (PAGs) can be mutually beneficial in a number of key areas.
1:02:03
-
Play video Panel discussion - Setting the roadmap for optimizing cancer clinical trials
Panel discussion - Setting the roadmap for optimizing cancer clinical trials
59:59
-
Play video The changing face of cell and gene therapy Impacts on planning and executing trials
The changing face of cell and gene therapy Impacts on planning and executing trials
32:11
-
Play video The importance of early planning in cell & gene therapy commercialization
The importance of early planning in cell & gene therapy commercialization
1:01:11
-
Play video Implementing novel development strategies for cell & gene therapy clinical trials
Implementing novel development strategies for cell & gene therapy clinical trials
1:00:47
-
Play video Navigating the future of cell & gene therapy - the potential for broader indication
Navigating the future of cell & gene therapy - the potential for broader indication
58:33
- Load More